Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Orchard Therapeutics plc (ORTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Mar-05-23 | Dec-31-22 | Dec-05-22 | Sep-30-22 | Jun-30-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-K | 8-K | 10-Q | 10-Q |
| Revenues | 100.0% | | 100.0% | | 100.0% | | 100.0% | 100.0% |
| Cost of goods sold | 31.1% | | 30.3% | | 29.9% | | 26.9% | 25.2% |
| Gross profit | 68.9% | | 69.7% | | 70.1% | | 73.1% | 74.8% |
| Selling, general and administrative | 565.6% | | 700.0% | | | | 889.8% | 1279.6% |
| General and administrative | | | | | 159.5% | | | |
| EBITDA | -328.6% | | -750.5% | | -777.9% | | -1398.5% | -1588.1% |
| Depreciation | 12.5% | | 14.6% | | 12.1% | | 16.7% | 23.3% |
| EBIT | -341.1% | | -765.1% | | -790.0% | | -1415.2% | -1605.2% |
| Pre-tax income | -409.9% | | -687.2% | | -675.5% | | -1115.9% | -1462.6% |
| Income taxes | -10.3% | | -13.3% | | -10.5% | | -6.9% | -10.1% |
| Net income | -399.6% | | -673.9% | | -665.0% | | -1109.0% | -1452.5% |
|